Abstract
The current understanding of addiction is based on a biopsychosocial model of illness. From a neurobiological perspective, addiction can be seen as the hijacking of the pleasure-reward pathways of the brain with a concomitant weakening of its executive function. The fundamental model has been expanded to include newer concepts such as multiple levels of severity of illness, motivational circuitry, and anti-reward pathways. These neurobiological concepts can explain some of the successes and failures of addiction treatment in the second half of the 20th century and the beginning of the 21st century. Psychosocial interventions (primarily cognitive behavior therapy, mutual help groups, and motivational interviewing) and pharmacological treatments (such as agonists, antagonists, and partial agonists) form the basis of addiction treatment today.
Similar content being viewed by others
References
Volkow ND, Baler RD. Addiction science: uncovering neurobiological complexity. Neuropharmacology. 2014;76(Part B):235–49.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013.
Levounis P, Arnaout B. Motivation and change: a practical guide for clinicians. Washington, DC: American Psychiatric Press; 2010.
McCabe SE, Hughes TL, Bostwick WB, West BT, Boyd CJ. Sexual orientation, substance use behaviors and substance dependence in the United States. Addiction. 2009;104(8):1333–45.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Levounis, P. Bench to Bedside: From the Science to the Practice of Addiction Medicine. J. Med. Toxicol. 12, 50–53 (2016). https://doi.org/10.1007/s13181-015-0515-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-015-0515-7